Deals
Kenvue Ties Feminine-Care Sales And Bond Covenant Removal To Kimberly-Clark Deal Closing
Kenvue's quarterly report now cites regulator-driven divestitures and a $7 billion note exchange, all contingent on the merger.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Deals
Kenvue's quarterly report now cites regulator-driven divestitures and a $7 billion note exchange, all contingent on the merger.
Earnings
The shopping-center landlord also posted 33.7% rent gains on new leases and won a Fitch upgrade to BBB+.
Earnings
The electrical equipment maker also raised its full-year adjusted earnings forecast to $5.36 to $5.39 a share.
Earnings
Sanofi collaboration revenue rose 68% in the third quarter, and Regeneron raised its 2026 research spending range while cutting its SG&A range.
SEC Filings
The Tylenol maker's operating margin widened to 18.2% and nine-month free cash flow reached $1.6 billion.
SEC Filings
The ski-resort operator's board urges rejection of four activist nominees and one self-nominated candidate before the December 14 annual meeting.
Earnings
Adjusted earnings edged up to $0.87 a share while reported profit fell from $0.86, and PECO's storm costs weighed on its results.
Earnings
Third-quarter net income rose to $179.1 million on lower costs, and capital spending fell 73% to $21.5 million.
Earnings
DXC's growth unit got a lift from a favorable contract modification, while its Consulting unit's goodwill test cleared by 13%.
Earnings
Revenue edged up 1% to C$619 million, and the uranium producer narrowed its 2026 output and delivery ranges.
SEC Filings
The new loan facility arrives as trailing-twelve-month free cash flow turned to a $42.4 billion outflow.
SEC Filings
CCC shares closed at $7.68 Thursday, under the $7.75 cash offer from a GTCR-led group that includes Elliott.